These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36714014)

  • 1. Design of hACE2-based small peptide inhibitors against spike protein of SARS-CoV-2: a computational approach.
    Dhingra N; Bhardwaj R; Bhardwaj U; Kapoor K
    Struct Chem; 2023 Jan; ():1-14. PubMed ID: 36714014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2).
    Egieyeh S; Egieyeh E; Malan S; Christofells A; Fielding B
    PLoS One; 2021; 16(1):e0245258. PubMed ID: 33417604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 4. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
    Shi L; Wen Z; Song Y; Wang J; Yu D
    J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
    Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiple-step
    Zhai J; He X; Man VH; Sun Y; Ji B; Cai L; Wang J
    Phys Chem Chem Phys; 2022 Feb; 24(7):4305-4316. PubMed ID: 35107459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening.
    Hu X; Cui J; Chen J; Du S; Wang X; Zhang Y; Qian J; Chen H; Wei F; Cai Q; Jia J; Wu J
    Virus Res; 2022 Nov; 321():198915. PubMed ID: 36084746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
    Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
    Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
    Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
    Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
    Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
    Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.
    Sakib MMH; Nishat AA; Islam MT; Raihan Uddin MA; Iqbal MS; Bin Hossen FF; Ahmed MI; Bashir MS; Hossain T; Tohura US; Saif SI; Jui NR; Alam M; Islam MA; Hasan MM; Sufian MA; Ali MA; Islam R; Hossain MA; Halim MA
    Comput Biol Med; 2021 Sep; 136():104759. PubMed ID: 34403938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
    Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
    Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational simulation appraisal of banana lectin as a potential anti-SARS-CoV-2 candidate by targeting the receptor-binding domain.
    Hessel SS; Dwivany FM; Zainuddin IM; Wikantika K; Celik I; Emran TB; Tallei TE
    J Genet Eng Biotechnol; 2023 Nov; 21(1):148. PubMed ID: 38015308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction.
    Wang C; He F; Sun K; Guo K; Lu S; Wu T; Gao X; Fang M
    Int J Biol Macromol; 2023 Jul; 244():125182. PubMed ID: 37276898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
    Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.